Synlogic and Caldera Therapeutics Announce Definitive Merger Agreement
July 29, 2026
Synlogic and Caldera Therapeutics entered into a definitive all-stock merger agreement to combine into a newly formed holding company, with the combined company operating as Caldera Therapeutics, Inc. The transaction is expected to close in early 2027 and includes a concurrent upsized private placement expected to generate approximately $278 million to fund Phase 2 development of CLD-423.
- Buyers
- Caldera Therapeutics, Inc., Synlogic, Inc., Newly formed holding company (to operate as Caldera Therapeutics, Inc.)
- Targets
- Synlogic, Inc., Caldera Therapeutics, Inc.
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.